AVISAN MULTI
Injectable emulsion
NAME OF ACTIVE PRINCIPLES:
Composition per dose (0.5 ml):
Avian infectious bronchitis virus, inactivated, strain H52................... HAI 1: 2 6 – 2 8
Newcastle disease virus, inactivated, La Sota strain......................... HAI 2: 2 4 – 2 6
Egg drop syndrome virus, inactivated, Adenovirus-127 strain.............. HAI 1: 2 7 – 2 9
1Mean titre haemagglutination inhibition after inoculation of a dose of vaccine to SPF chicks.
2Mean titre haemagglutination inhibition after inoculation of 1/50 of a dose of vaccine to SPF chicks.
INDICATIONS:
Hens: Active immunization of future layers chicks as of 16-week of age for protection against the virus of Newcastle disease, the egg drop syndrome´76 virus and against a drop in production and quality of laying caused by the Massachusetts serotype of Avian infectious Bronchitis virus. The efcacy of the vaccine has only been tested prior to vaccination with live attenuated virus against the infectious avian bronchitis virus and against the Newcastle disease virus. The vaccine protects poultry up to 65 weeks of age.
CONTRAINDICATIONS:
Layers: The effects of administering the product once laying has started have not been investigated. Therefore, do not administer during the laying period.
ADVERSE REACTIONS:
Microscopic lesions may be seen at the injection site (lymphoid proliferation, in ammatory reaction the day following administration and granulomatous in ammation) that will disappear by 7 days post-vaccination.
TARGET SPECIES:
Poultry (hens – future layers).
DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION:
Hens: 0.5 ml/animal. Administer one dose, when 16 weeks of age by subcutaneous route in the mid-dorsal part of the neck, in the opposite direction to the head.
RECOMMENDATION FOR CORRECT ADMINISTRATION:
It is advisable to allow the vaccine to reach ambient temperature (+15 ºC to +25 ºC) before administering it. Shake well before use and from time to time during administration. Use sterile material when administering the vaccine. Administer properly by subcutaneous route since intradermal administration can cause a localised oedema that will evolve favourably. Do not inject in cervical vertebrae.
WITHDRAWAL PERIOD:
0 days.
SPECIAL STORAGE PRECAUTIONS:
Keep out of reach and sight of children. Store refrigerated (between +2 ºC and +8 ºC). Do not freeze. In use shelf life: 10 hours.
SPECIAL WARNINGS:
Special precautions to be taken by the person administering the medicament to animals:
Precautions to the user: This product contains mineral oil. Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or nger, and in rare cases could result in the loss of the affected nger if prompt medical attention is not given. If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package lea et with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
Precautions to the physician: This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischemic necrosis and even the loss of a digit. PROMPT expert, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where nger pulp or tendon is involved. There is no information available as to the safety and efcacy of the use of this vaccine with any other type of veterinary medicament. The decision to use this vaccine either before or after the administration of any other veterinary medicament must be taken on a case-by-case basis. Do not mix with any other vaccine or immunological product.
SPECIAL PRECAUTIONS TO BE TAKEN WHEN DISPOSING OF UNUSED VACCINE OR WASTE
MATERIALS FROM IT:
All unused veterinary drugs or waste deriving from them must be disposed of in conformity with local laws and regulations.
PRESENTATION: 1.000 doses (500 ml) bottle.